Cargando…
Reclassification of TCGA Diffuse Glioma Profiles Linked to Transcriptomic, Epigenetic, Genomic and Clinical Data, According to the 2021 WHO CNS Tumor Classification
In 2021, the fifth edition of the WHO classification of tumors of the central nervous system (WHO CNS5) was published. Molecular features of tumors were directly incorporated into the diagnostic decision tree, thus affecting both the typing and staging of the tumor. It has changed the traditional ap...
Autores principales: | Zakharova, Galina, Efimov, Victor, Raevskiy, Mikhail, Rumiantsev, Pavel, Gudkov, Alexander, Belogurova-Ovchinnikova, Oksana, Sorokin, Maksim, Buzdin, Anton |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9820617/ https://www.ncbi.nlm.nih.gov/pubmed/36613601 http://dx.doi.org/10.3390/ijms24010157 |
Ejemplares similares
-
Better Agreement of Human Transcriptomic and Proteomic Cancer Expression Data at the Molecular Pathway Activation Level
por: Raevskiy, Mikhail, et al.
Publicado: (2022) -
Human Blood Serum Inhibits Ductal Carcinoma Cells BT474 Growth and Modulates Effect of HER2 Inhibition
por: Kamashev, Dmitrii, et al.
Publicado: (2022) -
Transcriptomic Portraits and Molecular Pathway Activation Features of Adult Spinal Intramedullary Astrocytomas
por: Konovalov, Nikolay, et al.
Publicado: (2022) -
Spotlights on adult patients with pediatric-type diffuse gliomas in accordance with the 2021 WHO classification of CNS tumors
por: Chen, Wenlin, et al.
Publicado: (2023) -
Human blood serum can donor-specifically antagonize effects of EGFR-targeted drugs on squamous carcinoma cell growth
por: Kamashev, Dmitry, et al.
Publicado: (2021)